IDEXX Laboratories, Inc.IDXXNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

businesswire.com

IDEXX Announces CEO Succession

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026, at which time Jonathan (Jay) Mazelsky, President and CEO, will transition to the role of Executive Chair of IDEXX's Board of Directors (the “Board”). Mr. Mazelsky has announced his intention to retire from the Company immediately following the Comp.

defenseworld.net

Commonwealth Equity Services LLC Sells 898 Shares of IDEXX Laboratories, Inc. $IDXX

Commonwealth Equity Services LLC lowered its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,407 shares of the company's stock after selling 898 shares during the period. Commonwealth Equity Services

businesswire.com

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2025 Earnings Snapshot through a link on.

youtube.com

Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB

CNBC's “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.

zacks.com

IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?

IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.

defenseworld.net

Railway Pension Investments Ltd Has $189.45 Million Stake in IDEXX Laboratories, Inc. $IDXX

Railway Pension Investments Ltd raised its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 92.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 296,530 shares of the company's stock after buying an additional 142,200 shares during the

defenseworld.net

Gateway Investment Advisers LLC Decreases Holdings in IDEXX Laboratories, Inc. $IDXX

Gateway Investment Advisers LLC cut its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 19.9% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,444 shares of the company's stock after selling 2,595 shares during the quarter. Gateway Investment Advisers LLC's

defenseworld.net

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Recommendation of “Moderate Buy” from Brokerages

IDEXX Laboratories, Inc. (NASDAQ: IDXX - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective

zacks.com

3 ESG Stocks to Add to Your Portfolio for Sustainable Returns in 2026

NVIDIA, IDXX and Microsoft shine on ESG metrics, fueling investor interest with strong returns and ambitious 2030 goals.

zacks.com

Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.

zacks.com

3 Medical Instrument Stocks to Counter Industry Woes Using GenAI

VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.

feeds.benzinga.com

From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026

Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.

defenseworld.net

Atossa Genetics (NASDAQ:ATOS) & IDEXX Laboratories (NASDAQ:IDXX) Head-To-Head Survey

IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) and Atossa Genetics (NASDAQ: ATOS - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Profitability This table compares IDEXX Laboratories and Atossa

defenseworld.net

Chapin Davis Inc. Invests $5.07 Million in IDEXX Laboratories, Inc. $IDXX

Chapin Davis Inc. purchased a new position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 7,934 shares of the company's stock, valued at approximately $5,069,000. IDEXX Laboratories makes up about 1.2% of Chapin Davis Inc.'s investment

defenseworld.net

Assenagon Asset Management S.A. Sells 6,863 Shares of IDEXX Laboratories, Inc. $IDXX

Assenagon Asset Management S.A. reduced its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 10.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,868 shares of the company's stock after selling 6,863 shares during the period. Assenagon Asset Management S.A. owned

defenseworld.net

Corient Private Wealth LLC Sells 3,030 Shares of IDEXX Laboratories, Inc. $IDXX

Corient Private Wealth LLC lessened its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 2.5% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 117,474 shares of the company's stock after selling 3,030 shares during the quarter. Corient Private Wealth LLC

zacks.com

4 Medical Device Stocks to Buy for Healthy Returns in 2026

ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.

defenseworld.net

Bamco Inc. NY Sells 27,157 Shares of IDEXX Laboratories, Inc. $IDXX

Bamco Inc. NY lessened its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 1.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,032,620 shares of the company's stock after selling 27,157 shares during the quarter. IDEXX Laboratories comprises about 3.0% of

defenseworld.net

Federated Hermes Inc. Has $15.79 Million Stock Position in IDEXX Laboratories, Inc. $IDXX

Federated Hermes Inc. lowered its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 7.3% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 29,444 shares of the company's stock after selling 2,313 shares during the period. Federated Hermes Inc.'s holdings in IDEXX Laboratories were

defenseworld.net

IDEXX Laboratories, Inc. $IDXX Shares Sold by Brant Point Investment Management LLC

Brant Point Investment Management LLC reduced its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 8.7% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 11,276 shares of the company's stock after selling 1,072 shares during the quarter. IDEXX Laboratories comprises about 0.6% of Brant Point

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance